Artículos de revistas
Dietary Fatty Acid Quality Affects Ar And Pparγ Levels And Prostate Growth
Registro en:
Prostate. , v. 69, n. 5, p. 548 - 558, 2009.
2704137
10.1002/pros.20905
2-s2.0-61949483298
Autor
Escobar E.L.O.
Gomes-Marcondes M.C.C.
Carvalho H.F.
Institución
Resumen
BACKGROUND. Fatty acids are among the most important nutritional factors associated with the ethiopathogenesis of prostate cancer, therefore the main objective of this work was to evaluate the effect of quality of fatty acid on the rat ventral prostate growth, tissue organization, and expression of androgen receptor (AR) and peroxisome proliferation activator receptor g (PPARγ). METHODS. Wistar rats were distributed into five groups, which were fed isocaloric normolipidic diets containing soybean oil (7% Control), linseed (7% or 3.5% linseed plus 3.5% soybean oil) and rendered pork fat (7% or 3.5% lard plus 3.5% soybean oil) for 10 weeks after weaning. RESULTS. At the end of treatment, the experiments demonstrated that lard and linseed oil caused opposite effects on prostatic growth. While the lard promoted an increase in prostatic weight associated to epithelial hyperplasia (confirmed by stereology); the linseed resulted in a significantly lighter organ. Immunohistochemistry and Western blotting demonstrated increased expression of AR and PPARγ in groups fed with lard diet, while linseed oil promoted a decrease. CONCLUSIONS. Prostatic growth is influenced by dietary fatty acids with concurrent variation in the expression of AR and PPARγ. PPARγ might represent the link between diet and prostate growth and AR expression and function. Since the levels of testosterone were altered it is also possible that prostatic changes are secondary to systemic effects of the diet. © 2009 Wiley-Liss, Inc. 69 5 548 558 Dhom, G., Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate (1983) Journal of Cancer Research and Clinical Oncology, 106 (3), pp. 210-218 Chaudry, A., McClinton, S., Moffat, L.E.F., Wahle, K.W.J., Essential fatty acids distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease (1991) Br J Cancer, 64, pp. 1157-1160 Rowley, K.H., Mason, M.D., The aetiology and patogenesis of prostate cancer (1997) Clin Oncol R Coll Radiol, 9, pp. 213-218 Mamalakis, G., Kafatos, A., Karagelopoulos, N., Andrikolopoulos, N., Daskalopoulos, G., Kranidis, A., Prostate cancer vs hiperplasia: Relationships with prostatic and adipose tissue fatty acid composition (2002) Prostagl Leukotr Essent Fatty Acids, 66, pp. 467-477 Hankey, B.F., Feuer, E.J., Clegg, L.X., Hayes, R.B., Legler, J.M., Prorok, P.C., Ries, L.A., Kaplan, R.S., Cancer surveillance series: Interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates (1999) J Natl Cancer Inst, 91, pp. 1017-1024 Fleshner, N., Bagnell, P.S., Klotz, L., Venkateswaran, V., Kristal, A.R., Thompson, I.M., Klein, E., Ford, L.G., Dietary fat and prostate cancer (2004) Journal of Urology, 171 (2), pp. S19-S24. , DOI 10.1097/01.ju.0000107838.33623.19 Shennan, D.H., Bishop, O.S., Diet and the mortality from malignant disease in 32 countries (1974) West Indian Med J, 23, pp. 44-53 Blair, A., Fraumeni Jr., J.F., Geographic patterns of prostate cancer in the United States (1978) Journal of the National Cancer Institute, 61 (6), pp. 1379-1384 Carroll, K.K., Khor, H.T., Dietaty fat in relation to tumorigenesis (1975) Prog Biochem Pharmacol, 10, pp. 308-353 Kolonel, L.N., Nomura, A.M., Cooney, R.V., Dietary fat and prostate cancer: Current status (1999) J Natl Cancer Inst, 91, pp. 414-428 Myers, C.E., Ghosh, J., Lipoxygenase inhibition in prostate cancer (1999) European Urology, 35 (5-6), pp. 395-398. , DOI 10.1159/000019915 Zhu, Y.S., Katz, M.D., McGinley, I., Lessons from human genetic models (1998) Bailleres Clin Endocrinol Metab, 12, pp. 83-113 Cunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J., Sugimura, Y., The endocrinology and developmental biology of the prostate (1987) Endocr Rev, 8, pp. 338-362 Ross, R.K., Henderson, B.E., Do diets and androgens alter prostate cancer risk via a common etiologic pathway? (1994) J Natl Cancer Inst, 86, pp. 252-254 Dorgan, J.F., Judd, J.T., Longcope, C., Brown, C., Schatzkin, A., Clevidence, B.A., Campbell, W.S., Taylor, P.R., Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study (1996) Am J Clin Nutr, 64, pp. 850-855 Issemann, I., Green, S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators (1990) Nature, 347 (6294), pp. 645-650. , DOI 10.1038/347645a0 Zhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A., Capone, J.P., Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase 3-hydroxyacyl-CoA- dehydrogenase (1992) Proc Natl Acad Sci USA, 89, pp. 7541-7545 Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M.G., Wahli, W., Fatty acids eicosanoids are ligands for peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay (1997) Mol Endocrinol, 11, pp. 770-791 Segawa, Y., Yoshimura, R., Hase, T., Hase, T., Nakatani, T., Wada, S., Kawahito, Y., Sano, H., Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer (2002) Prostate, 51, pp. 108-116 Willson, T.M., Lambert, M.H., Kliewer, S.A., Peroxisome proliferator-activated receptor gamma and metabolic disease (2001) Annual Review of Biochemistry, 70, pp. 341-367. , DOI 10.1146/annurev.biochem.70.1.341 Sporn, M.B., Suh, N., Mangelsdorf, D.J., Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs) (2001) Trends in Molecular Medicine, 7 (9), pp. 395-400. , DOI 10.1016/S1471-4914(01)02100-1, PII S1471491401021001 Rosen, E.D., Spiegelman, B.M., PPARgamma: A Nuclear Regulator of Metabolism, Differentiation, and Cell Growth (2001) Journal of Biological Chemistry, 276 (41), pp. 37731-37734 Nwankwo, J.O., Robbins, M.E.C., Peroxisome proliferator-activated receptor-gamma expression in human malignant and normal brain, breast and prostate-derived cells (2001) Prostaglandins Leukotrienes and Essential Fatty Acids, 64 (4-5), pp. 241-245. , DOI 10.1054/plef.2001.0266 Han, S., Roman, J., Peroxisome proliferator-activated receptor gamma: A novel target for cancer therapeutics? (2007) Anticancer Drugs, 18 (3), pp. 237-244 Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D.S., Oh, W., Kantoff, P.W., Effects of ligand activation of peroxisome proliferator-activated receptor g human prostate cancer (2000) Proc Natl Acad Sci USA, 97, pp. 10990-10995 Buyukbabani, N., Mitchell, S.H., Tindall, D.J., Young, C.Y.F., Non-apoptotic cell death associated with S-phase arrest of prostate cancer cells via peroxisome proliferator-activated receptor γ ligand, 15-deoxy-12,14-prostaglandin J12 (2000) Cell Growth Differ, 11, pp. 49-61 Li, W.-D., Lee, J.H., Price, R.A., The peroxisome proliferator-activated receptor gamma2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose (2000) Molecular Genetics and Metabolism, 70 (2), pp. 159-161. , DOI 10.1006/mgme.2000.2999 Reeves, P.G., Nielsen, F.H., Fahey Jr., G.C., AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet (1993) J Nutr, 123, pp. 1939-1951 Kondo, Y., Homma, Y., Aso, Y., Kakizoe, T., Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats (1994) Cancer Research, 54 (23), pp. 6129-6132 Wang, Y., Corr, J.G., Thaler, H.T., Tao, Y., Fair, W.R., Heston, W.D., Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet (1995) J Natl Cancer Inst, 87, pp. 1456-1462 Garcia-Florez, M., Oliveira, C.A., Carvalho, H.F., Early effects of estrogen on the rat ventral prostate (2005) Brazilian Journal of Medical and Biological Research, 38 (4), pp. 487-497 Vilamaior, P.S.L., Taboga, S.R., Carvalho, H.F., Postnatal growth of the ventral prostate in Wistar rats: A stereological and morphometrical study (2006) Anat Rec, 288 A, pp. 885-892 Fritz, W.A., Wang, J., Eltoum, I.-E., Lamartiniere, C.A., Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate (2002) Molecular and Cellular Endocrinology, 186 (1), pp. 89-99. , PII S0303720701006633 Gad, S.C., Weil, C.S., Statistic for toxicologists (1994) Principles and Methods of Toxicology, pp. 221-274. , Wallace H, editor. New York: Raven Press Giles, G., Ireland, P., Diet, nutrition and prostate cancer (1997) International Journal of Cancer, 72 (SUPPL.), pp. 13-17 Cai, X., Haleem, R., Oram, S., Cyriac, J., Jiang, F., Grayhack, J.T., Kozlowski, J.M., Wang, Z., High fat diet increases the weight of rat ventral prostate (2001) Prostate, 49 (1), pp. 1-8. , DOI 10.1002/pros.1112 Cai, G., Huang, H., Shapiro, E., Zhou, H., Yeh, S., Melamed, J., Greco, M.A., Lee, P., Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate (2005) Journal of Urology, 173 (6), pp. 2190-2193. , DOI 10.1097/01.ju.0000158119.34126.70 Wahle, K.W., Heys, S.D., Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis (2002) Prostagl Leukotr Essent Fatty Acids, 67, pp. 183-186 Bidoli, E., Talamini, R., Bosetti, C., Negri, E., Maruzzi, D., Montella, M., Franceschi, S., La Vecchia, C., Macronutrients, fatty acids, cholesterol and prostate cancer risk (2005) Ann Oncol, 16, pp. 152-157 Feldman, B.J., Feldman, D., The development of androgen-independent prostate cancer (2001) Nature Reviews Cancer, 1 (1), pp. 34-45 Sciarra, F., Toscano, V., Role of estrogens in human benign prostatic hyperplasia (2000) Archives of Andrology, 44 (3), pp. 213-220 Håå G, P., Bektic, J., Bartsch, G., Klocker, H., Eder, I.E., Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells (2005) J Steroid Biochem Mol Biol, 96, pp. 251-258 Freeman, V.L., Meydani, M., Hur, K., Flanigan, R.C., Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma (2004) Cancer, 101 (12), pp. 2744-2754. , DOI 10.1002/cncr.20676 Bravi, F., Bosetti, C., Dal Maso, L., Talamini, R., Montella, M., Negri, E., Ramazzotti, V., La Vecchia, C., Food groups and risk of benign prostatic hyperplasia (2006) Urology, 67 (1), pp. 73-79. , DOI 10.1016/j.urology.2005.07.030, PII S009042950501126X Hardman, W.E., (n-3) fatty acids and cancer therapy (2004) J Nutr, 134 (12 SUPPL.), pp. 3427S-3430S Kota, B.P., Huang, T.H.-W., Roufogalis, B.D., An overview on biological mechanisms of PPARs (2005) Pharmacological Research, 51 (2), pp. 85-94. , DOI 10.1016/j.phrs.2004.07.012, PII S104366180400194X Subbarayan, V., Sabichi, A.L., Kim, J., Llansa, N., Logothetis, C.J., Lippman, S.M., Menter, D.G., Differential peroxisome proliferator-activated receptor-γ isoform expression and agonist effects in normal and malignant prostate cells (2004) Cancer Epidemiology Biomarkers and Prevention, 13 (11), pp. 1710-1716 Cury-Boaventura, F.M., Kanunfre, C.C., Gorjão, R., Martins De Lima, T., Curi, R., Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids (2006) Clin Nutr, 25, pp. 1004-1014 Sampath, H., Ntambi, J.M., Polyunsaturated fatty acid regulation of gene expression (2004) Nutrition Reviews, 62 (9), pp. 333-339. , DOI 10.1301/nr.2004.sept.333-339 Murtaugh, M.A., Ma, K.-N., Caan, B.J., Sweeney, C., Wolff, R., Samowitz, W.S., Potter, J.D., Slattery, M.L., Interactions of peroxisome proliferator-activated receptor, and diet in etiology of colorectal cancer (2005) Cancer Epidemiology Biomarkers and Prevention, 14 (5), pp. 1224-1229. , DOI 10.1158/1055-9965.EPI-04-0681